Individuals with type 2 diabetes may experience a somewhat slower rate and lower magnitude of weight loss compared to those without diabetes, as demonstrated in the SURMOUNT-2 trial
Brand-name products ship in temperature-controlled packaging validated through extensive stability testing
To better understand these shifts, we surveyed 500 UK residents using GLP-1 medications for weight loss
A great example of this is looking at the pancreas and thyroid function due to the potentially serious, albeit relatively rare, side effects causing pancreatitis or thyroid disorders
This is an essential factor owing to the loss of muscle oxidative capacity and mass in patients with type 2 diabetes, chronic obstructive pulmonary disease, and heart failure
Changes in electrical activity of the heart along with an increase in sympathetic tone, catecholamines (epinephrine or adrenaline, norepinephrine or noradrenaline) and cortisol can contribute to the development of heart palpitations